Penetration of meropenem into cysts in patients with autosomal dominant polycystic kidney disease (ADPKD).

Penetration of meropenem into cysts in patients with autosomal dominant polycystic kidney disease (ADPKD). - Intracystic penetration of MEPM in ADPKD.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011292

Enrollment

Registered

2013-07-26

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal or hepatic cyst infection in patients with autosomal dominant polycystic kidney disease (ADPKD).

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All ADPKD patients who are treated with intravenous MEPM and cyst drainage for infected cysts in Toranomon Hospital from August 2013.

Exclusion criteria

Exclusion criteria: Patients who do not agree to participate in this study will be excluded.

Design outcomes

Primary

Measure	Time frame
Serum and cyst fluid concentrations of MEPM.	—

Countries

Japan

Contacts

Public ContactTatsuya Suwabe, Satoshi Hamanoue

Toranomon Hospital Kajigaya Department of Nephrology

suwabe@toranomon.gr.jp+81-44-877-5111

Outcome results